Molecular and Immunological Evaluation of the Transcription Factor SOX-4 as a Lung Tumor Vaccine Antigen
Authors:
Open Access
- 1 March 2004
- journal article
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 172 (5) , 3319-3327
Abstract
The developmental transcription factor SOX-4 has been shown to be highly and differentially overexpressed in primary small cell lung carcinomas (SCLC). To examine the potential of SOX-4 for broad use as a lung cancer vaccine, we have evaluated the expression of SOX-4 in a panel of primary adenocarcinoma, squamous, and large cell tumor samples as well as in a panel of established small cell and non-small cell lung carcinoma tumor cell lines. SOX-4 mRNA is shown to be overexpressed in a substantial fraction of each of these lung tumor types. To examine the immunological potential of SOX-4, we have evaluated the presence of SOX-4-specific CD4 and CD8 T cells in PBMC of healthy donors and the presence of SOX4-specific Abs in sera from SCLC patients. We demonstrate the presence of both CD4 and CD8 T cells that recognize naturally processed epitopes derived from SOX-4 as well as the presence of SOX-4-specific Abs in sera from SCLC patients, but not in sera from healthy donors. The lung tumor-specific overexpression and demonstration of a comprehensive Ag-specific immune response specific for SOX-4 support the use of this molecule in the development of whole gene-, peptide-, or protein-based vaccination strategies against lung cancer. Furthermore, the identification of naturally processed T cell and Ab epitopes from SOX-4 provides valuable tools for the development of peptide-based vaccination strategies against lung cancer as well as to monitor SOX-4-specific responses in vaccinated patients.Keywords
This publication has 40 references indexed in Scilit:
- p185HER‐2/neu and p21CIP1/WAF1 Expression in Primary Tumors and Lymph Node Metastases in Non‐small Cell Lung CancerJapanese Journal of Cancer Research, 2002
- New genes involved in cancer identified by retroviral taggingNature Genetics, 2002
- Identification of genes over-expressed in small cell lung carcinoma using suppression subtractive hybridization and cDNA microarray expression analysisOncogene, 2002
- L552S, an alternatively spliced isoform of XAGE-1, is over-expressed in lung adenocarcinomaOncogene, 2001
- Identification of genes differentially over-expressed in lung squamous cell carcinoma using combination of cDNA subtraction and microarray analysisOncogene, 2000
- Review Article The immunology and immunotherapy of breast cancer: an updateInternational Journal of Immunopharmacology, 1999
- Sox‐4 facilitates thymocyte differentiationEuropean Journal of Immunology, 1997
- High-mobility-group proteins and cancer?an emerging linkJournal of Cancer Research and Clinical Oncology, 1997
- Translocations in solid tumoursCurrent Opinion in Genetics & Development, 1996
- Proliferating dendritic cell progenitors in human blood.Journal of Experimental Medicine, 1994